Literature DB >> 9972995

Measures of disease activity, damage, and health status: the Hopkins Lupus Cohort experience.

M Petri1, S G Barr, A Zonana-Nach, L Magder.   

Abstract

Mesh:

Year:  1999        PMID: 9972995

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.

Authors:  Loes van den Berg; Hans Nossent; Ole Rekvig
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

2.  Prednisone, lupus activity, and permanent organ damage.

Authors:  Mae Thamer; Miguel A Hernán; Yi Zhang; Dennis Cotter; Michelle Petri
Journal:  J Rheumatol       Date:  2009-02-04       Impact factor: 4.666

3.  SLE-key(®) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(®).

Authors:  Chaim Putterman; Alan Wu; Anat Reiner-Benaim; D Scott Batty; Ignacio Sanz; Jim Oates; Keren Jakobi; Michelle Petri; Pennina Safer; Robert Gerwien; Rachel Sorek; Yakov Blumenstein; Irun R Cohen
Journal:  J Immunol Methods       Date:  2015-12-08       Impact factor: 2.303

4.  Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.

Authors:  Ashira Blazer; Binhuan Wang; Danny Simpson; Tomas Kirchhoff; Sean Heffron; Robert M Clancy; Adriana Heguy; Karina Ray; Matija Snuderl; Jill P Buyon
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.